Logo image of UFS

Domtar Corporation (UFS) Stock Fundamental Analysis

NYSE:UFS - New York Stock Exchange, Inc. - Common Stock

55.49  +0.01 (+0.02%)

After market: 55.49 0 (0%)

Fundamental Rating

2

Taking everything into account, UFS scores 2 out of 10 in our fundamental rating. UFS was compared to 9 industry peers in the Paper & Forest Products industry. UFS may be in some trouble as it scores bad on both profitability and health. UFS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year UFS was profitable.
UFS Yearly Net Income VS EBIT VS OCF VS FCFUFS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 0 200M -200M 400M

1.2 Ratios

Industry RankSector Rank
ROA 0.58%
ROE 1.04%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
UFS Yearly ROA, ROE, ROICUFS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 0 5 -5 10 -10

1.3 Margins

Industry RankSector Rank
OM 5.83%
PM (TTM) 0.71%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
UFS Yearly Profit, Operating, Gross MarginsUFS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 0 5 -5 10 15 20

More info and screens

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, UFS has less shares outstanding
Compared to 1 year ago, UFS has a worse debt to assets ratio.
UFS Yearly Shares OutstandingUFS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 20M 40M 60M
UFS Yearly Total Debt VS Total AssetsUFS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 1B 2B 3B 4B 5B

2.2 Solvency

UFS has an Altman-Z score of 2.54. This is not the best score and indicates that UFS is in the grey zone with still only limited risk for bankruptcy at the moment.
UFS has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Altman-Z 2.54
ROIC/WACCN/A
WACCN/A
UFS Yearly LT Debt VS Equity VS FCFUFS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

UFS has a Current Ratio of 2.78. This indicates that UFS is financially healthy and has no problem in meeting its short term obligations.
UFS has a Quick Ratio of 1.69. This is a normal value and indicates that UFS is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 2.78
Quick Ratio 1.69
UFS Yearly Current Assets VS Current LiabilitesUFS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 500M 1B 1.5B 2B 2.5B

More info and screens

3

3. Growth

3.1 Past

The earnings per share for UFS have decreased strongly by -88.40% in the last year.
The earnings per share for UFS have been decreasing by -36.64% on average. This is quite bad
The Revenue for UFS has decreased by -26.93% in the past year. This is quite bad
The Revenue has been decreasing by -7.05% on average over the past years.
EPS 1Y (TTM)-88.4%
EPS 3Y-49.24%
EPS 5Y-36.64%
EPS Q2Q%187.57%
Revenue 1Y (TTM)-26.93%
Revenue growth 3Y-10.81%
Revenue growth 5Y-7.05%
Sales Q2Q%-8.27%

3.2 Future

UFS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 80.74% yearly.
Based on estimates for the next years, UFS will show a decrease in Revenue. The Revenue will decrease by -3.20% on average per year.
EPS Next Y1321.01%
EPS Next 2Y310.25%
EPS Next 3Y154.93%
EPS Next 5Y80.74%
Revenue Next Year-12.6%
Revenue Next 2Y-6.04%
Revenue Next 3Y-4.68%
Revenue Next 5Y-3.2%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
UFS Yearly Revenue VS EstimatesUFS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B
UFS Yearly EPS VS EstimatesUFS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 163.21, which means the current valuation is very expensive for UFS.
Compared to an average S&P500 Price/Earnings ratio of 27.41, UFS is valued quite expensively.
The Price/Forward Earnings ratio is 9.70, which indicates a very decent valuation of UFS.
UFS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 35.19.
Industry RankSector Rank
PE 163.21
Fwd PE 9.7
UFS Price Earnings VS Forward Price EarningsUFS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.96
UFS Per share dataUFS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as UFS's earnings are expected to grow with 154.93% in the coming years.
PEG (NY)0.12
PEG (5Y)N/A
EPS Next 2Y310.25%
EPS Next 3Y154.93%

More info and screens

1

5. Dividend

5.1 Amount

With a yearly dividend of 0.85%, UFS is not a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.35, UFS's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.85%

5.2 History

UFS has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A
UFS Yearly Dividends per shareUFS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 0.5 1 1.5

5.3 Sustainability

DP0%
EPS Next 2Y310.25%
EPS Next 3Y154.93%
UFS Yearly Income VS Free CF VS DividendUFS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 0 200M -200M

More info and screens

Domtar Corporation

NYSE:UFS (11/29/2021, 8:42:58 PM)

After market: 55.49 0 (0%)

55.49

+0.01 (+0.02%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryPaper & Forest Products
Earnings (Last)N/A N/A
Earnings (Next)02-18 2022-02-18/bmo
Inst Owners2.16%
Inst Owner Change0%
Ins Owners0.21%
Ins Owner Change0%
Market Cap2.81B
Analysts46.67
Price Target56.25 (1.37%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.85%
Yearly Dividend0.46
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 163.21
Fwd PE 9.7
P/S 0.87
P/FCF N/A
P/OCF N/A
P/B 1.27
P/tB N/A
EV/EBITDA 6.96
EPS(TTM)0.34
EY0.61%
EPS(NY)5.72
Fwd EY10.31%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS63.57
BVpS43.69
TBVpSN/A
PEG (NY)0.12
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.58%
ROE 1.04%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 5.83%
PM (TTM) 0.71%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.78
Quick Ratio 1.69
Altman-Z 2.54
F-Score8
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-88.4%
EPS 3Y-49.24%
EPS 5Y-36.64%
EPS Q2Q%187.57%
EPS Next Y1321.01%
EPS Next 2Y310.25%
EPS Next 3Y154.93%
EPS Next 5Y80.74%
Revenue 1Y (TTM)-26.93%
Revenue growth 3Y-10.81%
Revenue growth 5Y-7.05%
Sales Q2Q%-8.27%
Revenue Next Year-12.6%
Revenue Next 2Y-6.04%
Revenue Next 3Y-4.68%
Revenue Next 5Y-3.2%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A